Astera Labs (NASDAQ:ALAB) Downgraded to “Hold” Rating by Wall Street Zen

Wall Street Zen lowered shares of Astera Labs (NASDAQ:ALAB) from a buy rating to a hold rating in a report published on Tuesday morning.

Several other equities analysts also recently weighed in on the stock. Stifel Nicolaus increased their price target on shares of Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Northland Capmk lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 22nd. TD Cowen reduced their price target on Astera Labs from $225.00 to $170.00 and set a “hold” rating on the stock in a report on Wednesday, November 5th. Deutsche Bank Aktiengesellschaft lifted their target price on Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a research report on Tuesday, September 2nd. Finally, Jefferies Financial Group raised their price target on Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a research report on Tuesday, July 22nd. Thirteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $181.59.

Astera Labs Price Performance

ALAB opened at $167.55 on Tuesday. The firm has a market capitalization of $28.30 billion, a PE ratio of 150.95, a price-to-earnings-growth ratio of 3.24 and a beta of 1.37. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90. The business’s 50-day moving average is $195.68 and its two-hundred day moving average is $142.59.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The business’s revenue for the quarter was up 103.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, sell-side analysts expect that Astera Labs will post 0.34 EPS for the current year.

Insider Buying and Selling

In other Astera Labs news, CEO Jitendra Mohan sold 91,441 shares of the stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the sale, the chief executive officer directly owned 2,170,877 shares of the company’s stock, valued at approximately $398,377,638.27. This trade represents a 4.04% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the transaction, the director owned 385,863 shares of the company’s stock, valued at approximately $66,858,482.01. The trade was a 32.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 434,480 shares of company stock valued at $77,881,380 in the last 90 days. Company insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Alliancebernstein L.P. boosted its position in Astera Labs by 114.2% during the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock worth $501,289,000 after purchasing an additional 4,478,741 shares in the last quarter. Atreides Management LP increased its position in Astera Labs by 153.3% during the 1st quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock worth $277,601,000 after purchasing an additional 2,815,614 shares in the last quarter. Vanguard Group Inc. boosted its position in Astera Labs by 29.6% during the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after purchasing an additional 2,751,747 shares during the period. FengHe Fund Management Pte. Ltd. acquired a new stake in shares of Astera Labs in the second quarter valued at about $106,772,000. Finally, Bank of Nova Scotia grew its holdings in Astera Labs by 3,742.2% during the 1st quarter. Bank of Nova Scotia now owns 964,400 shares of the company’s stock valued at $57,546,000 after purchasing an additional 939,300 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.